| FDA 510(k) clearance | A premarket notification submitted under 21 CFR Part 807, Subpart E, when applicable. | The device has been found substantially equivalent to a legally marketed predicate device for its stated intended use. | Clearance is not the same as FDA approval and does not guarantee clinical outcomes for every patient or use. |
| FDA product classification | Classification depends on the device type, intended use, risk profile, and applicable FDA regulations. | Helps the clinic confirm that the equipment is legally marketed for the intended ENT application. | Not every medical device requires a 510(k); some products may follow another pathway or may not be regulated as medical devices. |
| Intended-use statement | The labeling should define the device’s intended purpose, target users, patient population, and operating conditions. | Supports appropriate selection for examinations, diagnosis, treatment, monitoring, or visualization in ENT practice. | A device should not be used outside its cleared or labeled intended purpose without appropriate clinical, regulatory, and risk review. |
| ISO 13485:2016 certification | Certification to the ISO 13485:2016 quality-management-system standard by an independent certification body. | Indicates that the certified organization operates documented processes for design, production, quality control, and continual improvement. | ISO 13485 certification is not approval or clearance of a specific device and does not replace local regulatory requirements. |
| Risk management | ISO 14971:2019 provides a recognized framework for identifying hazards, estimating and controlling risks, and monitoring residual risks. | Encourages systematic control of risks related to electrical energy, heat, illumination, infection, software, and incorrect use. | Risk management reduces risk but cannot eliminate every hazard or guarantee zero adverse events. |
| Electrical and equipment safety | Applicable electrical-safety and electromagnetic-compatibility evidence should be available where relevant to the device. | Helps reduce hazards such as electric shock, overheating, interference, and unexpected equipment behavior. | The clinic must still follow installation, grounding, inspection, maintenance, and cleaning instructions. |
| Reprocessing and infection control | The manufacturer’s labeling should specify cleaning, disinfection, sterilization, reuse limits, and compatible chemicals when applicable. | Supports safe handling of ENT accessories and reusable components that may contact mucous membranes or non-intact skin. | Using an unvalidated method or incompatible chemical can damage equipment and compromise infection control. |
| Quality records and traceability | Quality systems commonly include lot or serial-number traceability, complaint handling, corrective actions, and change-control records. | Makes it easier to investigate failures, manage recalls, document maintenance, and protect patients and staff. | A certificate or document should be checked for its scope, validity period, issuing body, and covered site or product category. |
| Post-market monitoring | Manufacturers are expected to address complaints, incidents, field corrections, and other post-market quality information as applicable. | Provides an ongoing safety feedback mechanism after equipment enters clinical service. | Clinics should report suspected device problems through the appropriate regulatory and manufacturer channels. |